$4.27
0.12.4%
Last update: Oct 28, 4:46 PM
Atea Pharmaceuticals Inc
AVIRNASDAQ
Atea Pharmaceuticals (AVIR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.56 | $-0.56 | $-0.48 | $-0.43 |
| Actual | $-0.41 | $-0.57 | $-0.57 | $-0.53 |
| Surprise | +26.8% | -1.79% | -18.8% | -23.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.50 | $-0.57 | $-0.44 | $-0.45 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.41 | $-0.56 | 26.8 % |
| Q1 | May 12, 2026 | $-0.57 | $-0.56 | -1.79 % |
| Q4 | Mar 5, 2026 | $-0.57 | $-0.48 | -18.8 % |
| Q3 | Nov 12, 2025 | $-0.53 | $-0.43 | -23.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 10, 2022 | $0 | $3.33M | -100.0 % |
| Q4 | Feb 28, 2022 | $192.18M | $85.73M | 124.2 % |
